Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) where fluorinated aromatic structures enhance metabolic stability and bioavailability. The methoxymethoxy group acts as a protecting group for phenolic hydroxyls during multi-step syntheses, allowing selective reactions at other functional sites. Its carboxylic acid functionality enables coupling reactions to form esters or amides, making it valuable in constructing complex drug molecules. Commonly applied in research settings for designing analogs in medicinal chemistry programs targeting central nervous system disorders and inflammatory diseases.